Clinical Research Directory
Browse clinical research sites, groups, and studies.
MK-4646 Multiple Dose Trial in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-4646-003)
Sponsor: Merck Sharp & Dohme LLC
Summary
This study will examine if at least one dose level of MK-4646 can lower HIV-1 viral load in a person's blood by a certain amount. The goals of this study are to learn about the safety of MK-4646 and if people tolerate it; and how HIV-1 viral load may decrease after starting to take MK-4646.
Official title: Multiple Dose Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiretroviral Activity of MK-4646 Monotherapy in Antiretroviral Therapy-Naïve Participants With HIV-1
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
28
Start Date
2025-07-09
Completion Date
2026-06-22
Last Updated
2026-03-27
Healthy Volunteers
No
Conditions
Interventions
MK-4646
MK-4646 in capsular form administered orally
Locations (2)
PMSI Republican Clinical Hospital "T.Mosneaga" ( Site 0002)
Chisinau, Moldova
ARENSIA Exploratory Medicine ( Site 0001)
Bucharest, București, Romania